217 related articles for article (PubMed ID: 21833536)
1. Effects of the PPARG P12A and C161T gene variants on serum lipids in coronary heart disease patients with and without Type 2 diabetes.
Yilmaz-Aydogan H; Kurnaz O; Kurt O; Akadam-Teker B; Kucukhuseyin O; Tekeli A; Isbir T
Mol Cell Biochem; 2011 Dec; 358(1-2):355-63. PubMed ID: 21833536
[TBL] [Abstract][Full Text] [Related]
2. The meta-analysis of the association of PPARG P12A, C161T polymorphism and coronary heart disease.
Ding S; Liu L; Zhuge QC; Yu Z; Zhang X; Xie J; Hong W; Wang S; Yang Y; Chen B
Wien Klin Wochenschr; 2012 Oct; 124(19-20):671-7. PubMed ID: 22987045
[TBL] [Abstract][Full Text] [Related]
3. PPARgamma gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus.
Wan J; Xiong S; Chao S; Xiao J; Ma Y; Wang J; Roy S
Cardiovasc Diabetol; 2010 Mar; 9():13. PubMed ID: 20334678
[TBL] [Abstract][Full Text] [Related]
4. Different effects of PPARA, PPARG and ApoE SNPs on serum lipids in patients with coronary heart disease based on the presence of diabetes.
Yilmaz-Aydogan H; Kurnaz O; Kucukhuseyin O; Akadam-Teker B; Kurt O; Eronat AP; Tekeli A; Bugra Z; Ozturk O
Gene; 2013 Jul; 523(1):20-6. PubMed ID: 23583468
[TBL] [Abstract][Full Text] [Related]
5. PPARγ Pro12Ala and C161T polymorphisms in patients with acne vulgaris: Contribution to lipid and lipoprotein profile.
Saeidi S; Chamaie-Nejad F; Ebrahimi A; Najafi F; Rahimi Z; Vaisi-Raygani A; Shakiba E; Rahimi Z
Adv Med Sci; 2018 Mar; 63(1):147-151. PubMed ID: 29120856
[TBL] [Abstract][Full Text] [Related]
6. PPARG gene C161T CT/TT associated with lower blood lipid levels and ischemic stroke from large-artery atherosclerosis in a Han population in Guangdong.
Wei WM; Wu XY; Li ST; Shen Q
Neurol Res; 2016 Jul; 38(7):620-4. PubMed ID: 27264718
[TBL] [Abstract][Full Text] [Related]
7. Effect of the PPARγ C161T gene variant on serum lipids in ischemic stroke patients with and without type 2 diabetes mellitus.
Chehaibi K; Nouira S; Mahdouani K; Hamdi S; Rouis M; Slimane MN
J Mol Neurosci; 2014 Dec; 54(4):730-8. PubMed ID: 24841086
[TBL] [Abstract][Full Text] [Related]
8. Effect of the peroxisome proliferator-activated receptor-gamma C161T polymorphism on lipid profile in Brazilian patients with Type 2 diabetes mellitus.
Tavares V; Hirata RD; Rodrigues AC; Monte O; Salles JE; Scallissi N; Speranza AC; Gomes S; Hirata MH
J Endocrinol Invest; 2005 Feb; 28(2):129-36. PubMed ID: 15887858
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-gamma gene polymorphism and risk of cardiovascular disease in patients with diabetic nephropathy.
Szeto CC; Chow KM; Poon PY; Kwan BC; Li PK
Am J Nephrol; 2008; 28(5):715-22. PubMed ID: 18417957
[TBL] [Abstract][Full Text] [Related]
10. Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone.
Florez JC; Jablonski KA; Sun MW; Bayley N; Kahn SE; Shamoon H; Hamman RF; Knowler WC; Nathan DM; Altshuler D;
J Clin Endocrinol Metab; 2007 Apr; 92(4):1502-9. PubMed ID: 17213274
[TBL] [Abstract][Full Text] [Related]
11. Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case-control study and meta-analysis.
Qian Y; Li P; Zhang J; Shi Y; Chen K; Yang J; Wu Y; Ye X
Medicine (Baltimore); 2016 Aug; 95(32):e4299. PubMed ID: 27512842
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein A5 gene polymorphism -1131T-->C: association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese.
Yan SK; Cheng XQ; Song YH; Xiao XH; Bi N; Chen BS
Clin Chem Lab Med; 2005; 43(6):607-12. PubMed ID: 16006256
[TBL] [Abstract][Full Text] [Related]
13. PPARgamma gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression.
Liu Y; Yuan Z; Liu Y; Zhang J; Yin P; Wang D; Wang Y; Kishimoto C; Ma A
Am Heart J; 2007 Oct; 154(4):718-24. PubMed ID: 17892998
[TBL] [Abstract][Full Text] [Related]
14. [The glutamate-cysteine ligase catalytic subunit gene C-129T and modifier subunit gene G-23T polymorphisms and risk for coronary diseases].
Zuo HP; Xu WJ; Luo M; Zhu ZZ; Zhu GS
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):637-40. PubMed ID: 17961430
[TBL] [Abstract][Full Text] [Related]
15. Impact of the C1431T Polymorphism of the Peroxisome Proliferator Activated Receptor-Gamma (PPAR-γ) Gene on Fasted Serum Lipid Levels in Patients with Coronary Artery Disease.
Oladi M; Nohtani M; Avan A; Mirhafez SR; Tajbakhsh A; Ghasemi F; Asadi A; Elahdadi Salmani M; Mohammadi A; Hoseinzadeh L; Ferns GA; Ghayour Mobarhan M
Ann Nutr Metab; 2015; 66(2-3):149-154. PubMed ID: 25896411
[TBL] [Abstract][Full Text] [Related]
16. The Role of PPAR-gamma C161T Polymorphism in Colorectal Cancer Susceptibility.
Kurnaz-Gomleksiz O; Torun BC; Isbir T; Bulut T; Sokucu N; Yilmaz-Aydogan H; Canbay E
In Vivo; 2022; 36(4):1911-1915. PubMed ID: 35738614
[TBL] [Abstract][Full Text] [Related]
17. PPARgamma polymorphisms and cancer risk: a meta-analysis involving 32,138 subjects.
Xu W; Li Y; Wang X; Chen B; Liu S; Wang Y; Zhao W; Wu J
Oncol Rep; 2010 Aug; 24(2):579-85. PubMed ID: 20596649
[TBL] [Abstract][Full Text] [Related]
18. Lack of association between peroxisome proliferator-activated receptor-gamma-2 gene variants and the occurrence of coronary heart disease in patients with diabetes mellitus.
Blüher M; Klemm T; Gerike T; Krankenberg H; Schuler G; Paschke R
Eur J Endocrinol; 2002 Apr; 146(4):545-51. PubMed ID: 11916624
[TBL] [Abstract][Full Text] [Related]
19. Association between single nucleotide polymorphism rs11057401 of CCDC92 gene and the risk of coronary heart disease (CHD).
Xiao L; Shi D; Zhang H; Zhang Y; Liu Y; Lu H; Zheng Y
Lipids Health Dis; 2018 Feb; 17(1):28. PubMed ID: 29439709
[TBL] [Abstract][Full Text] [Related]
20.
Khounphinith E; Yin RX; Cao XL; Huang F; Wu JZ; Li H
Int J Med Sci; 2019; 16(6):864-871. PubMed ID: 31337960
[No Abstract] [Full Text] [Related]
[Next] [New Search]
